R619-M66-303: CMV51p> HCoV-OC43 S-2P-T4f-3C-His8-Strep2x2 Citations (2)

Originally described in: Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.
Esposito D, Mehalko J, Drew M, Snead K, Wall V, Taylor T, Frank P, Denson JP, Hong M, Gulten G, Sadtler K, Messing S, Gillette W Protein Expr Purif. 2020 Jun 4;174:105686. doi: 10.1016/j.pep.2020.105686. PubMed Journal

---

Articles Citing R619-M66-303: CMV51p> HCoV-OC43 S-2P-T4f-3C-His8-Strep2x2

Articles
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components. Jing L, Wu X, Krist MP, Hsiang TY, Campbell VL, McClurkan CL, Favors SM, Hemingway LA, Godornes C, Tong DQ, Selke S, LeClair AC, Pyo CW, Geraghty DE, Laing KJ, Wald A, Gale M Jr, Koelle DM. JCI Insight. 2022 Mar 22;7(6). pii: 158126. doi: 10.1172/jci.insight.158126. PubMed
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit. Hurlburt NK, Homad LJ, Sinha I, Jennewein MF, MacCamy AJ, Wan YH, Boonyaratanakornkit J, Sholukh AM, Jackson AM, Zhou P, Burton DR, Andrabi R, Ozorowski G, Ward AB, Stamatatos L, Pancera M, McGuire AT. Commun Biol. 2022 Apr 11;5(1):342. doi: 10.1038/s42003-022-03262-7. PubMed

If you have published an article using this material, please email us at to have your article added to this page.